semaglutide birth defects Is It Safe to Take When Pregnant? Semaglutide Use During Pregnancy

In all treated people, regardless of any gaps in their treatment, semaglutide showed a significant 29% risk reduction for heart attack, stroke and death from any cause compared with tirzepatide (over an average follow-up of 8.3 months for semaglutide and 8.6 months for tirzepatide)

Both medications are FDA-approved for chronic weight management and represent the most clinically significant advancement in non-surgical weight loss in decades

Physicians must consider individual risk for these side effects prior to initiating treatment

Weeks three and four solidify the adaptation

They provide calories without challenging the stomach

However, there is no evidence to support this claim